Novacea Report issue

For profit Phase 2 Phase 3
Founded: San Francisco CA United States (2001)
Status: Acquired by Transcept Pharmaceuticals (2009) → now Novo Nordisk (2023)

Organization Overview

First Clinical Trial
2002
NCT00055263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree